Insider Cluster (2 insiders) ·Filed Jul 20, 2026

INCY

INCYTE CORP
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $341K total
Actionable Insight • Neutral

The insider sales are too small to signal a bearish view. Monitor for any material changes in Incyte's pipeline or upcoming earnings, but this cluster alone does not warrant a trading action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
INCY ▲ +6.79% at T+20d
NEUTRAL call ✓ call won +6.79% · α vs SPY +2.67% · entry $115.65 → $123.50
Next anchor: T+60d in 10d
Latest observation: T+51 -4.79% FF3 residual α
Entry anchored
Jul 17, 03:59 PM ET
via exchange tick
T+1d
+1.50%
call +1.50% · α +0.67%
$117.39
settled 2mo ago
T+5d
+1.75%
call +1.75% · α +2.17%
$117.67
settled 2mo ago
T+20d
+6.79%
call +6.79% · α +2.67%
$123.50
settled 7w ago
T+60d
—
call — · α —
—
in 10d

Price Chart

Loading chart...

Executive Summary

Two senior Incyte executives (CMO and EVP of U.S. Commercial) sold a combined $341K in open-market stock on July 16, 2026, at ~$115/share. This is a very small cluster relative to Incyte's $23.4B market cap (~0.0015%), making it economically trivial. The sales coincide with a large batch of non-cash equity grants to multiple executives on the same date, suggesting the sales are likely liquidity-driven to cover tax obligations or diversify after vesting, not a bearish signal on fundamentals.

Key Financial Metrics

Direction
selling
Total Value
$341.1K
Insiders
2

Key Facts

  • Two C-suite insiders sold a combined $341K in open-market shares on July 16, 2026.
  • Total sales represent ~0.0015% of Incyte's $23.4B market cap — economically trivial.
  • Sales occurred on the same day as large non-cash equity grants to multiple executives, consistent with tax-withholding or diversification after vesting.
  • No insider open-market purchases were made in the cluster window.

Financial Impact

Total insider sales of $341K, representing ~0.0015% of market cap — immaterial.

dilution

Risk Factors

  • Insider sales could increase if the stock appreciates further, but this is routine post-vesting behavior.
  • No fundamental risk signaled by this cluster.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
52% bullish (33 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INCY-1784613996350
9 reports for INCY
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+60▲ +23.70%Jun 8, 2026
Filters
Rows
Reports for INCY — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$120.16 $122.19▼ −1.69%▼ −3.68%$115.30 (+4.04%)
Aug 7, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$121.55 $124.40▲ +2.34%▲ +3.26%$115.30 (−5.14%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$120.60 $124.50▲ +3.23%▲ +4.47%$115.30 (−4.39%)
Jul 28, 2026
9w ago
8-K
MIXED ★ 6/10
$129.93 $129.72▼ −0.16%▼ −3.54%$115.30 (−11.26%)
Jul 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$115.65 $123.50▲ +6.79%▲ +2.67%$115.30 (−0.30%)
Jul 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$115.65 $123.50▲ +6.79%▲ +2.67%$115.30 (−0.30%)
Jun 8, 2026
16w ago
8-K
BULLISH ★ 7/10
$100.64 $115.62▲ +14.88%▲ +13.25%$115.30 (+14.57%)
May 27, 2026
18w ago
DEFA14A
NEUTRAL ★ 3/10
$97.26 $108.46▲ +11.52%▲ +13.82%$115.30 (+18.55%)
Feb 28, 2026
30w ago
Institutional Cluster
BULLISH ★ 6/10
$99.73 $90.31▼ −9.45%▼ −1.51%$115.30 (+15.62%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 21, 2026